Related references
Note: Only part of the references are listed.Novel erythropoietin-based therapeutic candidates with extra N-glycan sites that block hematopoiesis but preserve neuroplasticity
Milagros Burgi et al.
BIOTECHNOLOGY JOURNAL (2021)
Trends in peptide drug discovery
Markus Muttenthaler et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
The hormetic dose-response mechanism: Nrf2 activation
Edward J. Calabrese et al.
PHARMACOLOGICAL RESEARCH (2021)
IUPred3: prediction of protein disorder enhanced with unambiguous experimental annotation and visualization of evolutionary conservation
Gabor Erdos et al.
NUCLEIC ACIDS RESEARCH (2021)
Erythropoietin and its derivatives: from tissue protection to immune regulation
Bo Peng et al.
CELL DEATH & DISEASE (2020)
The Many Facets of Erythropoietin Physiologic and Metabolic Response
Sukanya Suresh et al.
FRONTIERS IN PHYSIOLOGY (2020)
Mechanism of Coupled Folding-upon-Binding of an Intrinsically Disordered Protein
Paul Robustelli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease
Jose J. Jarero-Basulto et al.
PHARMACEUTICALS (2020)
Critical Role of Nrf2 in Experimental Ischemic Stroke
Lei Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology
Oksana Dmytriyeva et al.
NEUROBIOLOGY OF AGING (2019)
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
Kritika Mohan et al.
SCIENCE (2019)
Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
Federica Rey et al.
ASN NEURO (2019)
BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra
Andras Micsonai et al.
NUCLEIC ACIDS RESEARCH (2018)
Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress
C. Castillo et al.
REDOX BIOLOGY (2018)
EPO does not promote interaction between the erythropoietin and beta-common receptors
Karen S. Cheung Tung Shing et al.
SCIENTIFIC REPORTS (2018)
Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors
Ruoli Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
The Anti-Aging Effect of Erythropoietin via the ERK/Nrf2-ARE Pathway in Aging Rats
Haiqin Wu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2017)
Erythropoietin and co.: intrinsic structure and functional disorder
Vladimir N. Uversky et al.
MOLECULAR BIOSYSTEMS (2017)
Preconditioning in neuroprotection: From hypoxia to ischemia
Sijie Li et al.
PROGRESS IN NEUROBIOLOGY (2017)
Cell Death in the Developing Brain after Hypoxia-Ischemia
Claire Thornton et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
Seung-Jun Yoo et al.
CELL DEATH & DISEASE (2017)
Correlated receptor transport processes buffer single-cell heterogeneity
Stefan M. Kallenberger et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Erythropoietin's Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons
Lisa S. Foley et al.
ANNALS OF THORACIC SURGERY (2017)
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology
Kamyar Kalantar-Zadeh
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Neuroprotective effects of erythropoietin against sevoflurane-induced neuronal apoptosis in primary rat cortical neurons involving the EPOR-Erk1/2-Nrf2/Bach1 signal pathway
Dong-Xue Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Nrf2 signaling pathway: Pivotal roles in inflammation
Syed Minhaj Uddin Ahmed et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects
Oksana Dmytriyeva et al.
MEDIATORS OF INFLAMMATION (2016)
PEP-FOLD3: faster denovo structure prediction for linear peptides in solution and in complex
Alexis Lamiable et al.
NUCLEIC ACIDS RESEARCH (2016)
Erythropoietin Stimulates Tumor Growth via EphB4
Sunila Pradeep et al.
CANCER CELL (2015)
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
Ignacio Moraga et al.
CELL (2015)
Frequency modulation of ERK activation dynamics rewires cell fate
Hyunryul Ryu et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection
RuiRong Yuan et al.
NEUROTHERAPEUTICS (2015)
JPred4: a protein secondary structure prediction server
Alexey Drozdetskiy et al.
NUCLEIC ACIDS RESEARCH (2015)
Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy
Andras Micsonai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Solution structure of the transmembrane domain of the mouse erythropoietin receptor in detergent micelles
Qingxin Li et al.
SCIENTIFIC REPORTS (2015)
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases
Sandro Dattilo et al.
IMMUNITY & AGEING (2015)
A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury
Cheng Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Erythropoietin activates Keap1-Nrf2/ARE pathway in rat brain after ischemia
Huaxing Meng et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
Interplay between partner and ligand facilitates the folding and binding of an intrinsically disordered protein
Joseph M. Rogers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor
Sina M. Coldewey et al.
KIDNEY INTERNATIONAL (2013)
Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns
Stefan Bohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Erythropoietin in cancer: a dilemma in risk therapy
Yihai Cao
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Redox Signaling Pathways Involved in Neuronal Ischemic Preconditioning
John W. Thompson et al.
Current Neuropharmacology (2012)
A new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survival
Stanislava Pankratova et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Hematopoiesis
Michael A. Rieger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative Disorders
Vittorio Calabrese et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor
Stanislava Pankratova et al.
BRAIN (2010)
Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common β-chain heteroreceptor
Peter Kanellakis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells
Kursad Genc et al.
CELL BIOCHEMISTRY AND FUNCTION (2010)
Recombinant human erythropoietin (rhEPO) alleviates early brain injury following subarachnoid hemorrhage in rats: Possible involvement of Nrf2-ARE pathway
Jian Zhang et al.
CYTOKINE (2010)
Covering a Broad Dynamic Range: Information Processing at the Erythropoietin Receptor
Verena Becker et al.
SCIENCE (2010)
The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans
Julio Cesar Garcia Rodriguez et al.
THESCIENTIFICWORLDJOURNAL (2009)
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
Michael Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation
Sumaya N. Hamadmad et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells
Michael J. Pellegrino et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Statistical potential for assessment and prediction of protein structures
Min-Yi Shen et al.
PROTEIN SCIENCE (2006)
Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin
J Liu et al.
STROKE (2005)
Emerging biological roles for erythropoietin in the nervous system
M Brines et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Both proteasomes and lysosomes degrade the activated erythropoietin receptor
P Walrafen et al.
BLOOD (2005)
Derivatives of erythropoietin that are tissue protective but not erythropoietic
M Leist et al.
SCIENCE (2004)
Erythropoietin as an antiapoptotic, tissue-protective cytokine
P Ghezzi et al.
CELL DEATH AND DIFFERENTIATION (2004)
High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: Exploring the biologic effects of STAT5 overexpression
Y Royer et al.
DNA AND CELL BIOLOGY (2004)
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
M Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin
K Prass et al.
STROKE (2003)
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
S Erbayraktar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Statistical potentials for fold assessment
F Melo et al.
PROTEIN SCIENCE (2002)